Neurocode
Pre-clinicalNeuroCode offers CAP/CLIA-certified testing, pTau217 biomarker assays, and live cell diagnostics for Alzheimer’s, myasthenia gravis & more.
Founded
2018
Focus
Diagnostics
About
NeuroCode offers CAP/CLIA-certified testing, pTau217 biomarker assays, and live cell diagnostics for Alzheimer’s, myasthenia gravis & more.
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedMar 15, 2022
Company Info
TypePrivate
Founded2018
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile